Press release
Global Metastatic Cancer Drugs Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities
Metastatic Cancer Drugs
How Big Is the Metastatic Cancer Drugs Market Size Expected to Be by 2034?
The market size for metastatic cancer drugs has seen a consistent expansion over the past few years. Its projected growth will see it increase from $58.07 billion in 2024 to $60.36 billion in 2025, boasting a compound annual growth rate (CAGR) of 3.9%. Factors contributing to this growth during the historical period include the enhancement of chemotherapy, advancements in targeted treatments, discoveries in immunotherapy, successful clinical trials, and better diagnosis and staging techniques.
The market for metastatic cancer drugs is predicted to experience robust growth in the upcoming years, escalating to a value of $75.05 billion in 2029 with a compound annual growth rate (CAGR) of 5.6%. Factors contributing to this estimated growth during the forecast period include advancements in precision medicine, the development of therapies driven by biomarkers, progress in liquid biopsy techniques, a focus on patient-centric methods, and comprehensive genomic profiling. Key trends anticipated during the forecast period encompass the rise of combination therapies, progress in nanomedicine, enhanced support for long-term survival, strategies for early intervention, and improving health equity and access.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11941
What Are the Emerging Segments Within the Metastatic Cancer Drugs Market?
The metastatic cancer drugs market covered in this report is segmented -
1) By Drug Class: HER2 Inhibitors, Immune Checkpoints Inhibitors, PARP Inhibitors, Kinase Inhibitors, Other Drug Class
2) By Cancer: Breast Cancer, Lung Cancer, Liver Cancer, Hematological Cancer, Brain Cancer, Prostate Cancer, Pancreatic Cancer, Other Cancers
3) By Treatment: Chemotherapy, Immunotherapy, Hormonal Therapy, Surgery, Other Treatments
4) By Route Of Administration: Intravenous, Intramuscular, Oral, Other Routes Of Administration
5) By End-Users: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By HER2 Inhibitors: Trastuzumab, Ado-trastuzumab emtansine, Lapatinib
2) By Immune Checkpoint Inhibitors: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors
3) By PARP Inhibitors: Olaparib, Rucaparib, Niraparib
4) By Kinase Inhibitors: EGFR Inhibitors, BRAF Inhibitors, ALK Inhibitors
5) By Other Drug Classes: Chemotherapy Agents, Hormonal Therapies, Targeted Therapies
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11941&type=smp
What Long-Term Drivers Are Shaping Metastatic Cancer Drugs Market Trends?
The metastatic cancer drugs market is forecasted to grow, driven by the escalating incidences of metastatic cancers. Metastatic cancer is the severe stage of cancer where the cells spread to different parts of the body. As the number of metastatic cancer cases escalates, new cancer medicines for treating different varieties of metastatic cancer are being developed. Moreover, the increasing rate of cancer has led to a higher incidence of metastatic cancers. For instance, the Journal of the National Cancer Institute published in 2022 stated that by 2025, it is projected that there will be 0.69 million cases of people in the United States, living with metastatic breast, prostate, lung, colorectal, bladder cancer, or metastatic melanoma. The estimated number of American women living with metastatic breast cancer has surged to 168,000 this year, an increase from 155,000 last year. Therefore, the surge in metastatic cancer cases promotes the growth of the metastatic cancer drugs market.
Who Are the Top Competitors in Key Metastatic Cancer Drugs Market Segments?
Major companies operating in the metastatic cancer drugs market include Pfizer Inc., Johnson and Johnson Services Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, AstraZeneca plc, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Astellas Pharma Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Incyte Corporation, Ipsen SA, Seagen Inc., Exelixis Inc., Zymeworks Inc., Karyopharm Therapeutics Inc., CRISPR Therapeutics AG, Fate Therapeutics Inc., CytomX Therapeutics Inc., Spectrum Pharmaceuticals Inc., Intellia Therapeutics Inc., GlaxoSmithKline plc, Adaptimmune Therapeutics plc
What Metastatic Cancer Drugs Market Trends Are Gaining Traction Across Different Segments?
The metastatic cancer drugs market is currently experiencing a rise in product innovations. This key trend is prevalent as leading market participants focus on introducing new drugs to solidify their market status. For instance, Roche Pharma, a leading company based in Switzerland renowned for its pharmaceuticals and biotechnology, and committed to transforming healthcare through innovation, unveiled a breast cancer treatment drug in May 2022. PHESGO, the inaugural fixed-dose formulation in cancer treatment, ingeniously combines the monoclonal antibodies Perjeta and Herceptin with hyaluronidase, facilitating a subcutaneous injection alongside IV chemotherapy. This trailblazing treatment allows a 90% reduction in time spent at the clinic, vastly improving patient convenience. According to CEO V. Simpson Emmanuel of Roche Pharma India, it allows patients to dedicate more time to enjoyable activities, thereby enhancing their overall quality of life.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/metastatic-cancer-drugs-global-market-report
Which Regions Are Becoming Hubs for Metastatic Cancer Drugs Market Innovation?
North America was the largest region in the metastatic cancer drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metastatic cancer drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Metastatic Cancer Drugs Market?
2. What is the CAGR expected in the Metastatic Cancer Drugs Market?
3. What Are the Key Innovations Transforming the Metastatic Cancer Drugs Industry?
4. Which Region Is Leading the Metastatic Cancer Drugs Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Metastatic Cancer Drugs Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities here
News-ID: 3998902 • Views: …
More Releases from The Business Research Company
Emerging Markets And Increasing Disposable Income Fueling Diamond Market Growth: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Diamond Market Through 2025?
In the past few years, there has been a stable expansion in the diamond market size. The prediction is it will increase from $1.33 billion in 2024 to $1.39 billion in 2025, boasting a compound annual growth rate…
2025-2034 Nonmetallic Minerals Mining Support Activities Market Outlook: Key Dri …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Nonmetallic Minerals Mining Support Activities Industry Market Size Be by 2025?
In the past few years, there has been a robust expansion in the size of the nonmetallic minerals mining support activities market. It is projected to escalate from $34.04 billion in 2024 to $36.55 billion…
Professional Street Sweeper Industry Outlook 2025-2029: Market Set to Cross $3.1 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Professional Street Sweeper Market Size By 2025?
The market size of professional street sweepers has seen significant expansion in the past few years. The market, predicted to rise from $2.37 billion in 2024 to $2.5 billion in 2025, boasts a compound annual growth rate (CAGR)…
Key Trends Reshaping the Industrial Wet Dust Collector Market: Advanced Filtrati …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Industrial Wet Dust Collector Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a robust growth in the size of the industrial wet dust collector market. It is expected to swell from $1.89 billion in 2024 to $2 billion by 2025, showing a…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
